Boston Scientific | BSX - Eigenkapital Und Reserven

Aktienkurs
59.95
Täglich Wechseln
-2.12 -3.42%
Monatlich
-4.74%
Jährlich
-41.33%
Q2 Prognose
60.74




Eigenkapital Und Reserven Veränderung Datum
Abbott USD 52.13B 1.3B 2025-12
AtriCure USD 491.94M 15.43M 2025-12
Avanos Medical USD 778.2M 200K 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Boston Scientific USD 24.23B 1.58B 2025-12
CONMED USD 1.03B 24.83M 2025-12
Cooper Companies USD 8.36B 124.7M 2025-12
Danaher USD 52.95B 415M 2026-03
Dexcom USD 2.75B 19.9M 2025-12
Edwards Lifesciences USD 10.34B 132.6M 2025-12
Globus Medical USD 4.57B 174.42M 2025-12
Illumina USD 2.72B 342M 2025-12
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.52B 131.1M 2025-12
Integra LifeSciences USD 1.04B 5.89M 2025-12
Intuitive Surgical USD 17.47B 349.5M 2026-03
J&J USD 81.19B 358M 2026-03
Masimo USD 721.2M 88.8M 2025-12
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.58B 54.9M 2025-12
Stryker USD 21.78B 594M 2025-09
Tandem Diabetes Care USD 155.17M 22.2M 2025-12
Teleflex USD 3.12B 697.09M 2025-12
Zimmer Biomet Holdings USD 12.7B 68.3M 2025-12